Titan Medical Inc (TMDIF)

[flybabyfly]

McNally: We believe that 2017 will be a significant and successful year of progress for Titan.

With my appointment as CEO at the start of the year, I am thrilled for the opportunity to apply my leadership skills and medical device commercialization experience to the challenges and opportunities facing Titan Medical. We begin the year with strong business partners, significant product development accomplishments, and a core team with which we can execute. We expect to recruit and add complementary expertise to the team early in the year.

Early in January, we will be attending the J.P. Morgan Healthcare Conference in San Francisco. Our meeting schedule is completely full with prospective analysts that want to hear our story, potential investors, and business partners. In addition, we have been invited to present at three well-respected healthcare conferences. Once details are confirmed, we will post this information on our website.

Based on ever-evolving medical device technology and the regulatory environment, we have been conducting a very detailed and thorough review of our development timelines and milestone schedules. This year, we would like to improve on the transparency with which we communicate with our shareholders, while protecting the strategic advantage of confidential information. As we achieve meaningful operational and development milestones, we will promptly inform our shareholders.